Angiogenesis plays a pivotal role in breast cancer progression. Cyanidin-3-glucoside (C3G), one of the most widely distributed anthocyanins in edible fruits, shows antioxidative and anti-inflammatory property as well as induction of breast cancer cells apoptosis. However, the effect of C3G on breast cancer-induced angiogenesis remains unknown. In the present study, we found that C3G could attenuate breast cancerinduced angiogenesis via inhibiting VEGF, a key cytokine for angiogenesis, expression and secretion. Furthermore, signal transducer and activator of transcription 3 (STAT3) could transcriptionally activate VEGF, and C3G reduced STAT3 expression at both mRNA and protein level. Subsequently, our data showed that C3G induced miR-124 expression. Moreover, miR-124 could directly repress STAT3 expression, and miR-124-mediated STAT3 down-regulation was responsible for the inhibition of C3G on VEGF and angiogenesis. Taken together, we supplied more evidence to the antibreast cancer property of C3G.
| INTRODUCTION
Breast cancer has become the most common cancer type in females worldwide, resulting in more than 500,000 deaths every year (Torre et al., 2015) . Angiogenesis resulting from a complex process consisted of the interaction among tumor cells, vascular endothelial cells, phagocytes and various kinds of secreted cytokines plays a critical role in cancer growth, maintenance, and metastasis via providing oxygen, growth factors, nutrients, and vessels for cancer cellular infiltration and migration (Ricciuti et al., 2017) . Tumors lacking an adequate vasculature become apoptotic; however, tumors with abundant vasculatures may enter a phase of accelerated growth and exhibit increased metastatic property. Thus, targeting cancer angiogenesis has become a promising strategy for cancer therapy. Moreover, some anti-angiogenic drugs such as bevacizumab have been applied in clinical practice (Loizzi et al., 2017) .
Indeed, certain cytokines secreted by cancer cells are irreplaceable in cancer-induced angiogenesis. Among these, vascular endothelial growth factor (VEGF), the best characterized positive regulator of angiogenesis, exerts highly promoting effect for angiogenesis in pathophysiology, and its expression level in tumor was negatively associated with prognosis of patients with breast cancer (Shenoy et al., 2012) . After specific binding with VEGF receptors on the surface of vascular endothelial cells, intracellular signal pathways such as Ras/ Raf/MEK/ERK will be highly activated, leading to subsequent endothelial cells recruitment, proliferation, and final angiogenesis (Siveen et al., 2017) .
MicroRNAs (miRNAs) are a cluster of endogenous noncoding
RNAs consisted of approximately 22 nucleotides. Based on specific base pairing to target mRNA's 3′-untranslated region (3′-UTR) within the RNA-induced silencing complex (RISC), miRNAs can block the mRNA transcript translation or stimulate its degradation, leading to post-transcriptionally negative regulation of the target gene (Mingardi, Musazzi, De Petro, & Barbon, 2018) . Up to now, increasing evidence has confirmed that they serve as key regulators in various biological processes via modulation of enormous genes and their dys-regulation is implicated in many diseases including cancer and other disorders (Hosseinahli, Aghapour, Duijf, & Baradaran, 2018) . Indeed, miRNAs can promote or suppress cancer initiation and progression by targeting tumor suppressors or oncogenes, respectively. For example, miR-21, a well-known oncogenic miRNA, is involved in cancer biology via repressing numerous tumor suppressors such as PTEN, PDCD4, and SPRY1 (Mao et al., 2017) . However, the miR-200 family can attenuate the migratory and invasive capacity of cancer cells via reversion of epithelial-mesenchymal transition (O'Brien et al., 2018) .
Cyanidin-3-glucoside (C3G), one of the most widely distributed anthocyanins (ACNs) in edible fruits such as raspberries and strawberries, showed efficient radical scavenging capacity (RSC) against superoxide and anti-inflammatory property (Olivas-Aguirre et al., 2016) . And dietary C3G could ameliorate doxorubicin-induced cardiotoxicity in mice (Petroni et al., 2017) . In addition, previous study showed that C3G could suppress ethanol-induced invasion of breast cancer cells overexpressing ErbB2 via phosphorylation inhibition of ErbB2, Src, FAK, and p130 (Xu et al., 2010) . Moreover, C3G could also induce apoptosis in breast cancer by caspase-3 cleavage and DNA fragmentation (Cho et al., 2017) . However, the effect of C3G on breast cancer-caused angiogenesis and the role of miRNAs in it remain obscure. In consideration of the significance of angiogenesis during cancer progression, we will focus on it with model in vivo and in vitro. Grand Island, NY, USA), 100-mg/ml streptomycin, and 100-U/ml penicillin (Life Technologies/Gibco, Grand Island, NY, USA). MDA-MB-231 cells were maintained in a cell incubator without CO 2 at 37°C; Hs-578T cells were grown in the presence of 5% CO 2 . C3G (99.0% purity), dissolved in dimethyl sulfoxide (DMSO), was obtained from Sigma Chemical (St. Louis, MO, USA), and stored at −20°C. All the other reagents used in our present study were of analytical grade or the highest grade available.
| Western blotting
Cell lysis solution was obtained with RIPA lysis buffer containing 1-mM PMSF protease inhibitor (Beyotime Biotechnology, Shanghai, China).
The cell lysates were heated to 100°C for 15 min and separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by transferring to polyvinylidene fluoride membranes (PVDF; Millipore, Billerica, MA, USA). Then the membranes were blocked in 5% bovine serum albumin at room temperature for 1.0 hr. The primary antibodies were prepared at a dilution of 1:1000 within 5% bovine serum albumin at 4°C overnight on shaker. After gentle washing for 3-4 times by phosphate buffer solution, the membranes were incubated with specific horseradish peroxidase-conjugated secondary antibodies at a dilution of 1:1000. The antigen-antibody complexes were detected with enhanced chemiluminescence. Antibodies used in the study were anti-VEGF, anti-signal transducer and activator of transcription 3 (STAT3), anti-p-STAT3 (Cell Signaling Technology, Beverly, MA, USA), and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Beyotime Biotechnology, China). GAPDH served as the internal control. For densitometric analysis, the bands on blots were measured using the Eagle Eye II imaging system.
| Reverse-transcriptase polymerase chain reaction
Total cellular RNA was isolated withTrizol® (Invitrogen, USA) according to the manufacturer's protocols. RNA (2 μg) was transcribed into cDNA using AMV Reverse Transcriptase (Promega, Madison, WI, USA).
Primers used are listed in Table 1 . The reactions were determined by analyzing the PCR products on 2% (w/v) agarose gels. GAPDH product was applied as the loading control. For densitometric analysis, the bands on blots were measured using the Eagle Eye II imaging system.
| Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA from cells exposed to different treatments was isolated using Trizol® (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. For STAT3 detection, total RNA (2 μg) was reverse transcribed into cDNA with AMV Reverse Transcriptase (Promega, Madison, WI, USA). GAPDH was used as the internal control. The primers used in our study are listed in Table 1 Company, USA) that had polymerized for 30 min at 37°C. Subsequently, cells were incubated in the conditioned media as described above for another 6 hr. The number of tube branches was counted in every well using an Olympus light microscope (Tokyo, Japan).
| Chicken chorioallantoic membrane (CAM) assay
Fertilized chick embryos were preincubated for 9 days at 38°C with 70% humidity. The egg shells were cleaned with 75% ethanol. A hole was drilled over the air sac at the end of the eggs. A 1*1 cm window in the shell was made to expose the CAMs. Silastic rings were placed on avascular zone of the CAMs. MDA-MB-231 cells (1 × 10 6 ) were mixed with growth factor-reduced matrigel containing 0 or 20 μM of C3G in a total volume of 25 μl and incubated in the center of the silastic rings on the CAMs for 5 days. Later, stationary liquid consisted of equivalent methanol and acetone was added onto the CAMs for fixation at room temperature for 15 min. After coagulation of the blood in the vessels of the CAMs, the tumor samples were then cut out from the membrane and the CAMs around the tumor samples were harvested.
Then the CAMs were unfolded into a plate with normal saline. Lastly, the CAMs were put on a filter paper and photographed immediately.
| Chromatin immunoprecipitation assay (ChIP)
After individual treatment, Hs-578T cells were fixed by 1% formaldehyde for 10 min at 37°C. Then cells were washed twice with ice-cold phosphate buffer saline containing 1-mM PMSF, the inhibitor of protease, and then scraped. After centrifugation for 2 min at 4°C, the cells population was resuspended in SDS lysis buffer containing 1-mM PMSF for 15 min and then sonicated. The cell lysis sample was then centrifuged at 4°C for 10 min at 12,000 rpm. The supernatant was diluted in ChiP dilution buffer containing 1-mM PMSF. STAT3 antibody and IgG was added and incubated at 4°C overnight with gentle shaking. The immunocomplex was pulled down with protein A/G agarose and washed by low salt immune complex wash buffer, high salt immune complex wash buffer, LiCl immune complex wash buffer, and TE buffer in order. The complex was eluted with elution buffer containing 1% SDS and 0.1-M NaHCO 3 , and the cross-links was reversed by heating at 65°C for 4 hr. The DNA was then purified by phenol/chloroform and applied to the subsequent PCR amplification.
The sequence of primers used is as follows: VEGF promoter forward:
5′-CTGGCCTGCAGACATCAAAGTGAG-3′ and reverse: 5′-CTTCCC GTTCTCAGCTCCACAAAC-3′. For densitometric analysis, the bands on blots were measured using the Eagle Eye II imaging system.
| Cell transfection
Anti-con, anti-miR-124, mimic-con, and mimic-miR-124 were 
| Statistical analysis
Values were presented as the means ± SD. The one-way analysis of variance followed by Dunnett's t test were applied to determined statistical differences between groups. P values <0.01 were considered statistically significant.
3 | RESULTS
| C3G attenuates breast cancer-induced angiogenesis
First, we examined the effect of C3G on the angiogenesis induced by breast cancer cells. MDA-MB-231 and Hs-578T cells were pretreated by 0, 10, and 20 μM of C3G for 24 hr, then the media was removed to replace fresh media with 1% serum. After 24 hr, the conditioned media was collected, and we treated HUVECs with these conditioned media, respectively. As shown in Figure 1a 
| C3G inhibits STAT3 expression via upregulating miR-124
Former report suggested that miR-124 could attenuate STAT3 expression via base pairing with the 3′-UTR within STAT3 mRNA (Ma et al., 2018) . We therefore test the effect of miR-124 on STAT3. As shown in 
| C3G attenuates the angiogenesis induced by breast cancer cells via up-regulation of miR-124
As demonstrated in Figure 5 , C3G attenuated the angiogenesis induced by breast cancer cells, as determined by tube formation assay; however, inhibition of miR-124 abrogated such effects. These results suggested that induction of miR-124 was involved in the anti-angiogenic effect of C3G.
| DISCUSSION
On the basis of the data presented in our study, we firstly revealed that C3G attenuated STAT3 expression via inducing miR-124, leading to inhibition of the cytokine VEGF expression and secretion. Finally, breast cancer-caused angiogenesis was repressed.
Angiogenesis plays a key role for cancer initiation and subsequent progression via providing cancer cells with oxygen, nutrients, and vessels for metastasis. Therefore, targeting angiogenesis has become a promising strategy for cancer treatment in addition to conventional therapies such as radiotherapy and chemotherapy. However, current
anti-angiogenic therapeutic methods have relative side-effects after long-term applications. Currently, discovery of less toxic FIGURE 3 Down-regulation of signal transducer and activator of transcription 3 (STAT3) mediates the repressive effect of C3G on the expression and secretion of vascular endothelial growth factor (VEGF). Hs-578T cells were transiently transfected with negative control siRNA (si-nc) or STAT3 siRNA (si-STAT3) according to the protocol. Reverse-transcriptase polymerase chain reaction (a), western blotting (b), ChIP (c), and enzyme-linked immunosorbent (d) assay (mean ± SD, n = 3) were subsequently performed, ** p < 0.01, compared with the group transfected with negative control siRNA (si-nc). Hs-578T cells were exposed to C3G at 0, 10, and 20 μM for 24 hr. Reverse-transcriptase polymerase chain reaction (e), western blotting analysis (f), and ChIP assay (g) were carried out. (h) The relative enrichment of STAT3 within VEGF promoter was measured (mean ± SD, n = 3). ** p < 0.01, compared with the control group without C3G treatment. Modern pharmacological experiments showed that these catechins could effectively inhibit angiogenesis through numerous mechanisms such as modulation of certain microRNAs expression in cancer cells (Rashidi, Malekzadeh, Goodarzi, Masoudifar, & Mirzaei, 2017) .
Moreover, naturally occurring phytochemicals may be used for breast cancer therapy in combination with targeted agent (Dalasanur Nagaprashantha et al., 2018) . Recent evidence demonstrated that C3G, one of the most widely distributed ACNs, was able to inhibit phosphorylation of HER2, suppress migration, invasion, and cell growth of trastuzumab-resistant breast cancer (Li et al., 2016) . C3G
could also inhibit the aberrant proliferation of human epithelial colorectal adenocarcinoma Caco-2 cells (Liang, Guan, Shen, Xia, & Liu, 2017). Additionally, C3G could induce apoptosis of the glioblastoma cells via increasing Bax and P53, decreasing the expression of Bcl-2 (Hosseini et al., 2017) . In the present study, we found inhibition of breast cancer-induced angiogenesis by C3G treatment in dose-dependent manner. As for concreted mechanisms, down-regulation of VEGF expression and secretion, an important cytokine for angiogenesis, was responsible for such effect.
Previous evidence showed that interleukin-6 (IL-6)/STAT3 signaling played a central role in angiogenesis due to modulation of VEGF expression (Middleton, Jones, Lwin, & Coward, 2014) . Subsequently, we focused on IL-6/STAT3 pathway. Indeed, IL-6 has been known as a pro-inflammatory cytokine that participated in the path- Besides, previous data revealed that IL6Rα, a pivital molecule in transduction of IL-6/STAT3 signaling, was also a potentially direct gene target of miR-124 (Hatziapostolou et al., 2011) . It is reasonable to hypothesize that inhibition of IL6Rα by miR-124 may be also involved in repression of STAT3 phosphorylation by C3G, which needs further investigation.
In addition to STAT3, PI3K/AKT signaling activation also contributed to cancer-induced angiogenesis (Sasore, Reynolds, & Kennedy, 2014) . And miR-124 could negatively regulate the activity of PI3K/ AKT pathway . More attention should be paid to uncover whether PI3K/AKT signaling was involved in the inhibition of angiogenesis by miR-124 induction caused by C3G exposure in breast cancer cells.
In our study, we did not supply any data about the mechanisms responsible for the up-regulation of miR-124 by C3G. Former research suggested that DNA methylation of promoter CpG islands contributed to miR-124 silencing in breast cancer cells (Pronina et al., 2017) . Reactive oxygen species (ROS)-induced oxidant stress could silence certain gene expression via DNA methylation (Zhang et al., 2013) . And recruitment of DNA methyltransferases to target gene promoter plays a key role in ROS-induced DNA methylation (Wu & Ni, 2015) . As Taken together, our data firstly determined the effect of C3G on breast cancer-induced angiogenesis and the concrete mechanism responsible for such effect. By unmasking a novel mechanism whereby C3G, a kind of widely distributed ACNs in edible fruits, attenuates the angiogenesis caused by breast cancer, our study not only expands understanding of the anti-breast cancer property of C3G, but also provides an alternative for the prevention and therapeutics of breast cancer.
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